Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
Saved in:
| Title: | Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y |
|---|---|
| Authors: | Mathew RO; Department of Medicine, Loma Linda VA Health Care System, 11201 Benton Street, Loma Linda, CA, 92357, USA. Roy.mathew@va.gov., Sidhu MS; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA. mssidhu@yahoo.com., Rihal CS; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lennon R; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., El-Hajjar M; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA., Yager N; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA., Lyubarova R; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA., Abdul-Nour K; Henry Ford Health System, Detroit, MI, USA., Weitz S; Cardiology Associates of Schenectady, Schenectady, NY, USA., O'Cochlain DF; Department of Medicine, May Clinic Health System, Eau Claire, WI, USA., Murthy V; Department of Endocrine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA., Levisay J; Department of Medicine, North Shore University Health System, Evanston, IL, USA., Marzo K; Department of Medicine, Winthrop University Hospital, Mineola, NY, USA., Graham J; Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada., Dzavik V; Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada., So D; Department of Medicine, University of Ottawa Heart Institute, Ottawa, ON, Canada., Goodman S; Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada., Rosenberg YD; National Heart Lung and Blood Institute, Bethesda, MD, USA., Pereira N; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Farkouh ME; Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada. |
| Source: | Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Jun; Vol. 38 (3), pp. 447-457. Date of Electronic Publication: 2022 Nov 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36445624 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<subscript>12</subscript> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mathew+RO%22">Mathew RO</searchLink>; Department of Medicine, Loma Linda VA Health Care System, 11201 Benton Street, Loma Linda, CA, 92357, USA. Roy.mathew@va.gov.<br /><searchLink fieldCode="AU" term="%22Sidhu+MS%22">Sidhu MS</searchLink>; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA. mssidhu@yahoo.com.<br /><searchLink fieldCode="AU" term="%22Rihal+CS%22">Rihal CS</searchLink>; Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Lennon+R%22">Lennon R</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22El-Hajjar+M%22">El-Hajjar M</searchLink>; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA.<br /><searchLink fieldCode="AU" term="%22Yager+N%22">Yager N</searchLink>; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA.<br /><searchLink fieldCode="AU" term="%22Lyubarova+R%22">Lyubarova R</searchLink>; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA.<br /><searchLink fieldCode="AU" term="%22Abdul-Nour+K%22">Abdul-Nour K</searchLink>; Henry Ford Health System, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Weitz+S%22">Weitz S</searchLink>; Cardiology Associates of Schenectady, Schenectady, NY, USA.<br /><searchLink fieldCode="AU" term="%22O'Cochlain+DF%22">O'Cochlain DF</searchLink>; Department of Medicine, May Clinic Health System, Eau Claire, WI, USA.<br /><searchLink fieldCode="AU" term="%22Murthy+V%22">Murthy V</searchLink>; Department of Endocrine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Levisay+J%22">Levisay J</searchLink>; Department of Medicine, North Shore University Health System, Evanston, IL, USA.<br /><searchLink fieldCode="AU" term="%22Marzo+K%22">Marzo K</searchLink>; Department of Medicine, Winthrop University Hospital, Mineola, NY, USA.<br /><searchLink fieldCode="AU" term="%22Graham+J%22">Graham J</searchLink>; Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Dzavik+V%22">Dzavik V</searchLink>; Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22So+D%22">So D</searchLink>; Department of Medicine, University of Ottawa Heart Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Goodman+S%22">Goodman S</searchLink>; Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Rosenberg+YD%22">Rosenberg YD</searchLink>; National Heart Lung and Blood Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Pereira+N%22">Pereira N</searchLink>; Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Farkouh+ME%22">Farkouh ME</searchLink>; Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228712220%22">Cardiovascular drugs and therapy</searchLink> [Cardiovasc Drugs Ther] 2024 Jun; Vol. 38 (3), pp. 447-457. <i>Date of Electronic Publication: </i>2022 Nov 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+For+The+International+Society+For+Cardiovascular+Pharmacotherapy%22">Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8712220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209203206%22">09203206 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Drugs Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36445624 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10557-022-07392-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 447 Titles: – TitleFull: Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mathew RO – PersonEntity: Name: NameFull: Sidhu MS – PersonEntity: Name: NameFull: Rihal CS – PersonEntity: Name: NameFull: Lennon R – PersonEntity: Name: NameFull: El-Hajjar M – PersonEntity: Name: NameFull: Yager N – PersonEntity: Name: NameFull: Lyubarova R – PersonEntity: Name: NameFull: Abdul-Nour K – PersonEntity: Name: NameFull: Weitz S – PersonEntity: Name: NameFull: O'Cochlain DF – PersonEntity: Name: NameFull: Murthy V – PersonEntity: Name: NameFull: Levisay J – PersonEntity: Name: NameFull: Marzo K – PersonEntity: Name: NameFull: Graham J – PersonEntity: Name: NameFull: Dzavik V – PersonEntity: Name: NameFull: So D – PersonEntity: Name: NameFull: Goodman S – PersonEntity: Name: NameFull: Rosenberg YD – PersonEntity: Name: NameFull: Pereira N – PersonEntity: Name: NameFull: Farkouh ME IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2024 Jun Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1573-7241 Numbering: – Type: volume Value: 38 – Type: issue Value: 3 Titles: – TitleFull: Cardiovascular drugs and therapy Type: main |
| ResultId | 1 |
